Hericium erinaceus (Hericiaceae) Lion‘s Mane, Yamabushitake, Monkey Head Mushroom

Hericium erinaceus is one of the most extensively studied medicinal mushrooms, renowned globally for its remarkable neuroprotective and cognitive-enhancing properties. It is most notably recognized as a nootropic agent that supports brain health, promotes nerve regeneration, and offers therapeutic potential for neurodegenerative diseases including Alzheimer’s and Parkinson’s. Beyond neurology, it exhibits significant gastroprotective, immunomodulatory, anticancer, and antidepressant activities. Modern clinical research confirms its ability to stimulate Nerve Growth Factor and Brain-Derived Neurotrophic Factor synthesis, with recent 2025-2026 trials demonstrating improvements in visual attention, working memory, sleep quality, and mood in aging adults.

---

1. Taxonomic Insights

Species: Hericium erinaceus (Bull.) Pers.

Family: Hericiaceae

The Hericiaceae family comprises saprotrophic fungi belonging to the order Russulales, class Agaricomycetes. These fungi are characterized by their unique hydnoid (toothed) hymenophores, where spores are produced on tooth-like or spine-like projections rather than gills or pores. Hericium species are wood-decaying fungi, primarily found on hardwoods, playing an essential ecological role in decomposing lignin and cellulose in forest ecosystems.

Taxonomic Note: The species was first described by Pierre Bulliard in 1780 and later validated by Christian Hendrik Persoon in 1825. The genus name Hericium is derived from Latin “ericius” meaning hedgehog, referring to the spiny appearance of the fruiting body. The specific epithet erinaceus also means hedgehog in Latin. The mushroom is also known by synonyms including Hydnum erinaceus and Clavaria erinaceus.

Related Medicinal Fungi from the Same or Related Families:

· Hericium americanum (Bear‘s Head Tooth): A closely related North American species with a branched, coral-like structure, sharing similar neurotrophic and medicinal properties.

· Hericium coralloides (Coral Tooth Fungus): Another medicinal Hericium species with highly branched fruiting bodies, used similarly in traditional medicine.

· Hericium alpestre (Alpine Hericium): A less common species found in high-altitude regions, with documented medicinal applications.

· Ganoderma lucidum (Reishi): A fellow medicinal polypore, sharing immunomodulatory and neuroprotective properties, though with distinct compound classes.

---

2. Common Names

Scientific Name: Hericium erinaceus (Bull.) Pers. | English: Lion‘s Mane, Bearded Tooth Fungus, Monkey Head Mushroom, Hedgehog Mushroom, Pom Pom Mushroom | Japanese: 山伏茸 (Yamabushitake) | Chinese: 猴头菇 (Hóutóu gū), 猴头菌 (Hóutóu jūn) | Korean: 노루궁뎅이버섯 (Norugungdeng-i beoseot) | Sanskrit: Not documented in classical texts, recognized in modern mycological and Ayurvedic circles. | French: Hydne hérisson | German: Igelstachelbart | Italian: Testa di scimmia | Spanish: Melena de león | Hindi/South Asian: Regional names vary; commonly referred to by its English name Lion’s Mane in supplement markets.

---

3. Medicinal Uses

Primary Actions: Nootropic, Neuroprotective, Nerve growth stimulant, Antidepressant, Anxiolytic, Gastroprotective, Immunomodulatory, Antioxidant.

Secondary Actions: Anticancer, Anti-inflammatory, Antidiabetic, Hypolipidemic, Antimicrobial, Hepatoprotective, Prebiotic.

Medicinal Parts:

Both the fruiting body and mycelium are used medicinally, each containing distinct bioactive compound profiles.

· Fruiting Body: The mature mushroom, rich in hericenones (meroterpenoids) and polysaccharides (beta-glucans). Used extensively in traditional medicine for cognitive support and gastrointestinal health.

· Mycelium: The vegetative thread-like network, cultivated on substrates, uniquely rich in erinacines (cyathane diterpenoids). Requires solid-state cultivation for optimal erinacine production.

· Extracts: Hot water extracts (polysaccharides), ethanol extracts (hericenones, erinacines), and dual extraction methods are employed for therapeutic formulations.

---

4. Phytochemicals Specific to the Mushroom and Their Action

Key Neuroactive Compounds:

· Erinacines (A, B, C, E, F, H, I, S, Z1, Z2): A class of cyathane diterpenoids found exclusively in the mycelium. They are potent NGF inducers and Neuroprotective agents. Erinacine A is the most extensively studied, demonstrating ability to cross the blood-brain barrier, upregulate neurotrophin synthesis, activate the Nrf2 antioxidant pathway, and promote oligodendrocyte differentiation. Erinacine C shows anti-inflammatory effects via Nrf2 pathway modulation. Erinacine S is a newly characterized erinacine in the form of a polyol salt and a key bioactive in some standardized extracts.

· Hericenones (C, D, E, F, G, H, I, J): Meroterpenoids found primarily in the fruiting body. They function as NGF enhancers or signal potentiators, sensitizing downstream receptor machinery rather than directly inducing NGF synthesis. Hericenone E specifically potentiates NGF-induced neurite outgrowth in PC12 cells.

· Polysaccharides (Beta-glucans, Heteropolysaccharides): High molecular weight polysaccharides, predominantly beta-glucans, contribute to Immunomodulatory, Gastroprotective, Hypolipidemic, and Anticancer activities. They have documented prebiotic effects, increasing beneficial gut microbiota and short-chain fatty acid production.

· Herrcerins A-C: Isoindoline-1-one compounds with documented Neuroprotective and Antioxidant properties. Hericerin A has been shown to promote neurite outgrowth.

· Erinaceolactones (A, B): Additional secondary metabolites with potential bioactivity, though less characterized.

· Fatty Acids and Sterols: Various lipids and ergosterol derivatives contribute to Anti-inflammatory and Membrane-protective effects.

· Vitamins and Minerals: Rich in B vitamins (B1, B2, B3) and essential minerals including manganese, zinc, and potassium.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Wei Tong (Stomach Pain) & Chronic Atrophic Gastritis

Formulation: Dried mushroom decoction or soup.

Preparation & Use: In traditional Chinese medicine, Lion‘s Mane has been used for centuries to treat digestive disorders, particularly chronic atrophic gastritis and gastric ulcers. The mushroom is prepared as a soup or decoction and consumed regularly.

Reasoning: The polysaccharides form a protective coating on the gastric mucosa, reducing inflammation and promoting healing of ulcerated tissues. Modern research confirms the gastroprotective and anti-inflammatory effects.

Jian Nao Yi Zhi (Cognitive Enhancement & Dementia)

Formulation: Fruiting body powder or extract.

Preparation & Use: Traditional use includes consumption of the mushroom as a daily food or tonic to “nourish the five viscera, benefit the spleen, and augment wisdom.” It is particularly recommended for age-related cognitive decline.

Reasoning: The hericenones and erinacines stimulate NGF and BDNF synthesis in the brain, promoting neuronal survival, synaptic plasticity, and neurogenesis, particularly in the hippocampus. This provides a biological basis for its memory-enhancing effects.

Shen Jing Shuai Ruo (Neurasthenia & Nerve Weakness)

Formulation: Mycelial extract or whole mushroom decoction.

Preparation & Use: In traditional East Asian medicine, the mushroom is used to treat neurasthenia, a condition characterized by fatigue, anxiety, and depression, often following prolonged stress or illness.

Reasoning: Preclinical studies demonstrate that erinacines activate the BDNF/TrkB/PI3K/Akt/GSK-3β signaling axis, producing antidepressant-like effects in animal models. Human clinical trials confirm improvements in mood, sleep quality, and subjective wellbeing.

Xiao Yan (Inflammation)

Formulation: Extracts or dried powder.

Preparation & Use: Traditionally employed for its anti-inflammatory properties across various conditions.

Reasoning: Erinacines modulate cytokine levels, reducing pro-inflammatory mediators while increasing anti-inflammatory cytokine production. They prevent the activation of NF-κB and reduce expression of TNF-α, IL-1β, and IL-6.

---

6. Healing Recipes, Decoctions, and Preparations

Cognitive Support Decoction

Purpose: Daily brain health and memory support.

Preparation & Use:

1. Take 5-10 grams of dried Lion’s Mane mushroom (fruiting body), sliced or broken into small pieces.

2. Simmer in 500-750 ml of water for 30-60 minutes until softened.

3. The mushroom pieces can be eaten, and the broth consumed as tea. Honey may be added for taste. Consume 1-2 cups daily.

Traditional Medicinal Soup

Purpose: General tonic and immune support.

Preparation & Use:

1. Add 10-15 grams of dried Lion’s Mane to chicken or vegetable broth.

2. Simmer for 45-60 minutes.

3. Consume the mushroom pieces and broth as a nourishing meal.

Dual Extract Tincture (For Enhanced Bioactivity)

Purpose: Concentrated preparation for therapeutic use.

Preparation & Use:

1. Hot Water Extraction: Simmer 50g dried mushroom in 1 liter water for 2 hours. Strain and reserve liquid.

2. Alcohol Extraction: Cover the reserved cooked mushroom with 100ml of high-proof alcohol. Let sit for 4-6 weeks.

3. Combine both extracts. Take 1-3 ml up to three times daily. Note: Consult a qualified practitioner for appropriate dosing.

Standardized Supplement (Clinical Trial Doses)

Purpose: Evidence-based therapeutic dosing.

Preparation & Use:

· For cognitive impairment: 1.05 g mycelial fibers daily, standardized to contain 5 mg/g erinacine A.

· For general cognitive function: 3.2 g fruiting body powder once daily; or 1.8 g fruiting body and mycelial fibers after meals.

· For mild cognitive impairment: 1 g (96% dry powder) three times daily.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Hericium erinaceus (Lion‘s Mane)

Introduction

Hericium erinaceus has emerged as one of the most scientifically validated medicinal mushrooms of the 21st century, with its reputation transitioning from traditional Asian tonic to evidence-based nootropic and neurotherapeutic agent. The mushroom’s extraordinary neuropharmacological profile rests on two distinct classes of bioactive compounds: erinacines from the mycelium and hericenones from the fruiting body. A sophisticated emerging framework, grounded in preclinical research, proposes a functional dichotomy where erinacines primarily drive de novo synthesis of neurotrophic ligands, while hericenones sensitize downstream receptor machinery. The year 2025 proved pivotal for Lion’s Mane research, producing a systematic review of 26 human studies, multiple groundbreaking randomized controlled trials, a landmark systematic review of erinacine mechanisms, and a novel hypothesis proposing an epigenetic axis mediated by non-coding RNA networks. Recent 2026 trials have further solidified its cognitive benefits in mid-life and older adults. This comprehensive monograph synthesizes over two decades of research, from fundamental mechanisms of NGF induction to sophisticated clinical applications in Alzheimer‘s disease, Parkinson’s disease, depression, and gastrointestinal disorders.

1. Erinacines: The Signature Mycelial Neurotrophic and Nrf2-Activating Compounds

Key Compounds: Erinacine A, C, E, F, H, I, S, Z1, Z2. Erinacine A is the most extensively characterized.

Quantitative Profile: Standardized mycelial extracts typically contain 5 mg/g erinacine A. Erinacine A has a molecular weight of approximately 532.7 g/mol.

Actions and Clinical Relevance:

· NGF Induction (Primary and Clinically Relevant Mechanism): Erinacines potently induce NGF synthesis in glial cells, primarily astrocytes, which are the principal source of NGF in the central nervous system. They do not induce NGF directly in neurons but rather stimulate astrocytes to produce and secrete this critical neurotrophic factor. Multiple erinacines, including A, C, E, F, and H, have demonstrated this property in vitro. In vivo, oral administration of erinacine A (8 mg/kg) significantly increased NGF content in the rat hippocampus and locus coeruleus, brain regions essential for memory and arousal.

· Nrf2 Activation and Antioxidant Response (Unique Mechanism): A 2025 systematic review in Frontiers in Pharmacology revealed that erinacine A and C uniquely induce the accumulation of the transcription factor Nrf2, the master regulator of the cellular antioxidant response. Erinacine C has been shown to mediate protection against neuronal injury and microglial activation through the Nrf2 pathway in LPS-induced models. This mechanism, distinct from NGF induction, positions erinacines as bifunctional neuroprotective agents, simultaneously promoting growth factor synthesis and enhancing endogenous antioxidant defenses.

· Anti-inflammatory and Neuroprotection: Erinacines modulate cytokine levels, reducing pro-inflammatory mediators (TNF-α, IL-1β, IL-6) while increasing anti-inflammatory cytokine production. Erinacine A prevents dopaminergic degeneration in Parkinson‘s disease models by promoting pro-survival pathways and decreasing pro-apoptotic pathway activity. It also preserves astrocyte-enriched GLT-1 function, maintaining glutamate homeostasis, which is critical for preventing excitotoxicity.

· Neurogenesis and Oligodendrocyte Differentiation: Erinacine A and erinacine S promote oligodendrocyte differentiation, increasing myelin basic protein expression and the number of mature oligodendrocytes. Erinacine C has been shown to preserve astrocyte function under oxygen-glucose deprived conditions, maintaining glutamate homeostasis.

· Blood-Brain Barrier Penetration: Like hericenones, erinacines are small, lipophilic molecules capable of crossing the blood-brain barrier via passive diffusion, a prerequisite for direct CNS action that distinguishes them from larger mushroom polysaccharides.

2. Hericenones: The Fruiting Body Signal Potentiators and Enhancers

Key Compounds: Hericenones C, D, E, F, G, H, I, J.

Actions and Clinical Relevance:

· NGF Signal Potentiation (Distinct from Erinacines): Purified hericenones C, D, and E fail to directly stimulate NGF mRNA expression in cultured glial cells. However, hericenone E potentiates NGF-induced neurite outgrowth in PC12 cells. This has led to a refined functional model: erinacines drive de novo neurotrophin synthesis (ligand supply), while hericenones function primarily to sensitize downstream receptor machinery or potentiate signal transduction (signal amplification). This dual-action model suggests that whole extracts containing both hericenones and erinacines may offer superior therapeutic efficacy through synergy.

· Neuroprotection and Neurite Outgrowth: Hericenones support neuronal health by lowering the threshold for NGF receptor activation, effectively making neurons more responsive to available neurotrophic factors. This mechanism may be particularly valuable in conditions where NGF levels are only mildly deficient but neuronal responsiveness is compromised.

· Blood-Brain Barrier Penetration: Hericenones, as low molecular weight meroterpenoids, cross the blood-brain barrier, enabling direct action within the CNS.

3. Downstream Signaling Pathways: From Neurotrophin Induction to Neuronal Survival

Receptor Activation and Intracellular Cascades: Once synthesized and released, NGF and BDNF activate their respective high-affinity receptors, TrkA and TrkB. Preclinical evidence confirms that H. erinaceus compounds engage these receptor systems and their downstream signaling pathways.

· TrkA/Erk1/2 Pathway: The neuritogenic effects of H. erinaceus extracts and isolated compounds depend on the TrkA/Erk1/2 pathway. Differentiation of PC12 cells induced by conditioned media from erinacine C-treated astrocytes is mediated by TrkA and its downstream effectors.

· PI3K/AKT/mTOR Pathway (Pro-Survival): Erinacine A-enriched mycelium activates the full BDNF/TrkB/PI3K/Akt/GSK-3β signaling axis in mouse models of depression. This pathway inhibits apoptosis and promotes cellular growth.

· MAPK/ERK Pathway: Activation of MAPK/ERK, along with PI3K/AKT, converges on transcription factors such as CREB, promoting neuronal survival, neurite outgrowth, and synaptic plasticity.

4. Novel Mechanistic Frontier: The Neurotrophic-Epigenetic Axis

Hypothesis-Driven Framework (2026 Proposal): A 2026 review in the International Journal of Molecular Sciences proposed a novel framework suggesting that non-coding RNAs (ncRNAs) play a key regulatory role in the neuroprotective effects of H. erinaceus bioactives. The authors hypothesize that hericenones and erinacines modulate key transcriptional hubs such as CREB, Nrf2, and NF-κB, which in turn regulate the expression of specific ncRNAs (e.g., miR-132, miR-146a) known to control neurogenesis, synaptogenesis, oxidative stress, and neuroinflammation.

Significance: This ncRNA-mediated mechanism may represent an unexplored axis explaining the pleiotropic neuroprotective effects of H. erinaceus. If validated, it would reposition the mushroom‘s bioactives as modulators of complex gene regulatory networks rather than merely NGF-inducing agents, opening new therapeutic avenues for neurodegenerative diseases where multiple pathological mechanisms converge.

5. Clinical Evidence: Human Trials and Systematic Reviews (2025-2026)

Systematic Review of 26 Human Studies (2025): A comprehensive systematic review published in Frontiers in Nutrition evaluated all available human clinical data on H. erinaceus. Key findings include:

· Cognitive Function (Dementia and Mild Cognitive Impairment): Meta-analysis of randomized controlled trials and pilot clinical trials demonstrated that H. erinaceus supplementation improved Mini-Mental State Examination scores, with a combined weighted mean increase of 1.17 in the intervention group. Trials included patients with mild cognitive impairment and early Alzheimer‘s disease.

· Mood and Sleep Disorders: Human trials confirmed improvements in depression, anxiety, binge eating, and sleep disorders. One 4-week RCT in healthy women found reduced depression and anxiety scores. An 8-week RCT in patients with mood and sleep disorders showed significant improvements.

· Depression Mechanisms: Preclinical evidence shows that H. erinaceus enhances pro-BDNF and BDNF production, promotes hippocampal neurogenesis, and improves behavior.

· Gut Health: Clinical trials demonstrated increased gut microbiota diversity and abundance of short-chain fatty acid-producing bacteria, reducing inflammation and protecting gut health.

· Safety Profile: Side effects were rarely reported but included stomach discomfort, headache, allergic reactions, abdominal discomfort, nausea, and skin rash in isolated cases.

Acute vs. Chronic Effects (2025 RCT): A 2025 double-blind, placebo-controlled, crossover study in 18 healthy young adults (aged 18-35) investigated the acute effects of a single 3g dose of standardized H. erinaceus fruiting body extract (10:1). Results showed no significant effect on composite measures of global cognitive function and mood at 90 minutes post-consumption. However, participants exhibited improved performance on the pegboard test, a measure of psychomotor speed and fine motor coordination. The study concluded that acute consumption does not demonstrate overall cognitive improvement; any benefits may be task- or domain-specific. Chronic supplementation may be required for broader effects.

Chronic Supplementation in Aging Adults (2026 RCT): A 2026 randomized, double-blind, placebo-controlled trial (N=109, adults aged 40-75 with self-reported cognitive difficulty) evaluated 8 weeks of daily supplementation with 2g of whole H. erinaceus (fruiting body and mycelial biomass). Results:

· Cognitive Improvement: Significantly greater improvement in visual attention and working memory (Juggle Factor task) compared to placebo (p < 0.05).

· Sleep Quality: Subjective sleep quality and morning restedness improved significantly faster.

· Mood: Mood scores improved significantly more than placebo.

· Safety: No adverse events were reported.

· Funding Source: The study was funded by M2 Ingredients, with authors from the company reviewing but not altering analyses.

6. Anticancer and Additional Therapeutic Activities

Preclinical Cancer Research: A 2025 systematic review summarized laboratory studies demonstrating that isolated erinacine A inhibits the invasiveness of gastric cancer cells (MKN28 and TSGH 9201) and activates caspase pathways. Studies have also documented antiproliferative effects against leukemia (HL-60), liver cancer (HepG2, Huh-7), colon cancer (HT-29), breast cancer (MCF-7), and cervical cancer (HeLa) cells.

Gastroprotective Effects: Polysaccharides protect against gastric ulcers and chronic atrophic gastritis by forming a protective mucosal barrier, reducing inflammation, and promoting healing.

Immunomodulation and Anti-inflammatory: Beta-glucans activate macrophages and modulate immune function, while erinacines and hericenones reduce systemic inflammation through cytokine modulation and NF-κB inhibition.

Cardiometabolic Health: Emerging evidence suggests hypolipidemic effects, with reductions in LDL cholesterol and triglycerides in preclinical models.

An Integrated View of Healing in Hericium erinaceus

· For Neurodegenerative Diseases (Alzheimer‘s and Parkinson’s): H. erinaceus offers a sophisticated multi-level strategy. First, neurotrophin restoration: Erinacines stimulate NGF and BDNF synthesis in astrocytes, and hericenones potentiate downstream receptor signaling. Second, amyloid pathology intervention: Preclinical studies demonstrate prevention of β-amyloid plaque formation, a hallmark of Alzheimer‘s. Third, anti-inflammatory protection: Erinacines reduce microglial activation and neuroinflammation. Fourth, antioxidant defense: Nrf2 activation by erinacines A and C enhances endogenous antioxidant systems. Fifth, neurogenesis: Promotion of hippocampal neurogenesis and synaptic plasticity supports cognitive reserve. The systematic review’s finding of a 1.17-point improvement in MMSE scores across multiple trials provides quantitative clinical validation.

· For Mood Disorders, Sleep, and Well-being: The mushroom functions as a comprehensive neuropsychiatric tonic. The BDNF/TrkB/PI3K/Akt/GSK-3β pathway activation produces antidepressant-like effects. The 8-week RCT in 77 patients with mood and sleep disorders demonstrated significant improvements. The 2026 RCT showed faster improvements in sleep quality, morning restedness, and mood with 8 weeks of supplementation. This is not a sedative effect but rather a restorative normalization of neurotrophic support.

· For Cognitive Health in Aging: The 2026 RCT in adults aged 40-75 with subjective cognitive concerns provides the most robust evidence to date for real-world cognitive benefits. Improvements in visual attention and working memory, combined with better sleep and mood, suggest that the mushroom supports multiple domains essential for functional independence in aging.

· For Gastrointestinal Health: The polysaccharides provide prebiotic support, increasing beneficial gut bacteria and short-chain fatty acid production. The hericenones and erinacines may also exert local anti-inflammatory effects in the gut, supporting the traditional use in chronic gastritis.

· As a Source of Anticancer Lead Compounds: Erinacine A’s inhibition of gastric cancer cell invasion and activation of caspase pathways, combined with documented cytotoxicity against multiple cancer cell lines, positions this compound as a promising lead for oncological drug development.

Toxicological Profile and Safety

H. erinaceus has an excellent safety profile based on extensive traditional consumption, preclinical toxicology, and human clinical trials. The 2025 systematic review of 26 human studies concluded that side effects are rarely reported; when they occur, they include mild gastrointestinal discomfort, headache, and allergic reactions. Isolated cases of abdominal discomfort, nausea, and skin rash have been reported. One case report noted acute respiratory distress syndrome, though this was in the context of consuming a dry powder extract as a diet food, and causality is unclear. The 2026 RCT specifically reported no adverse events in participants receiving 2g daily for 8 weeks. Caution is advised for individuals with mushroom allergies. Pregnant and breastfeeding women should consult healthcare providers before therapeutic use.

Conclusion: Hericium erinaceus has earned its reputation as a premier medicinal mushroom for brain health through two decades of rigorous scientific investigation. The discovery of erinacines and hericenones, the elucidation of their distinct yet complementary mechanisms in NGF induction and signal potentiation, and the recent unveiling of Nrf2 activation as a unique erinacine property have positioned this fungus at the forefront of neurotherapeutic research. The 2025-2026 clinical trials, systematic reviews, and mechanistic studies have provided robust evidence for its efficacy in cognitive function, mood regulation, and sleep quality, while the novel hypothesis of an ncRNA-mediated neurotrophic-epigenetic axis opens exciting new frontiers for understanding its pleiotropic effects. As the global burden of neurodegenerative diseases and mental health disorders continues to rise, H. erinaceus stands as an accessible, cost-effective, and scientifically validated intervention, bridging the gap between traditional wisdom and evidence-based integrative medicine.

---

Disclaimer:

Hericium erinaceus is generally recognized as safe based on extensive traditional use and clinical trial data. Side effects are rare but may include mild gastrointestinal discomfort, headache, or allergic reactions in sensitive individuals. Individuals with mushroom allergies should avoid use. Those on anticoagulant, antidiabetic, or immunosuppressive medications should consult healthcare providers before therapeutic use. Pregnant and breastfeeding women should seek professional advice. Quality varies by source, cultivation method, and extraction process; standardized extracts with documented erinacine or hericenone content are recommended for therapeutic use. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Medicinal Mushrooms: A Clinical Guide by Martin Powell

· Hericium erinaceus: Lion’s Mane Mushroom and Its Medicinal Properties by various authors (research monographs)

· Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact by Shu-Ting Chang and Philip G. Miles

· Handbook of Medicinal Mushrooms by S.P. Wasser

· Fungi: Experimental Methods in Biology by Ramesh Maheshwari

---

9. Further Study: Fungi That Might Interest You Due to Similar Medicinal Properties

1. Ganoderma lucidum (Reishi)

· Species: Ganoderma lucidum | Family: Ganodermataceae

· Similarities: Both are premier medicinal mushrooms with immunomodulatory, neuroprotective, and adaptogenic properties. Reishi is more renowned for its calming, sleep-promoting, and cardiovascular benefits, while Lion’s Mane is specifically celebrated for its direct neurotrophic and nootropic effects. Together, they represent complementary approaches to brain health and stress resilience.

2. Hericium americanum (Bear’s Head Tooth)

· Species: Hericium americanum | Family: Hericiaceae

· Similarities: A close North American relative sharing the genus and similar phytochemical profiles, including bioactive compounds with neurotrophic properties. It is used interchangeably with H. erinaceus in some traditional contexts and represents an understudied source of neuroprotective compounds.

3. Grifola frondosa (Maitake)

· Species: Grifola frondosa | Family: Grifolaceae

· Similarities: Both are rich in beta-glucans with immunomodulatory and metabolic benefits. Maitake is more researched for its D-fraction in cancer immunotherapy and blood sugar regulation. Lion’s Mane stands alone for its direct neurotrophic and cognitive-enhancing effects, making them complementary functional foods.

4. Lentinula edodes (Shiitake)

· Species: Lentinula edodes | Family: Marasmiaceae

· Similarities: The most commercially significant medicinal mushroom globally, shiitake shares immunomodulatory polysaccharides (lentinan) and cardiovascular benefits. While Lion’s Mane uniquely supports neurite growth and NGF synthesis, shiitake offers well-documented cholesterol-lowering and antiviral properties. Both exemplify the integration of culinary and medicinal mushroom use.

---

-x-x-x-End-x-x-x-